Several combinations have been proposed, such as the SAFE biopsy algorithm for the non-invasive assessment of liver fibrosis, which consists of APRI and a commercialized method (Fibrotest-Fibrosure) [53] or the combination of GP73, glypican-3, and AFP for the diagnosis of HCC [54]. This evidence concerns the gene GPC3 and Hepatic fibrosis.